I

India Glycols Ltd
NSE:INDIAGLYCO

Watchlist Manager
India Glycols Ltd
NSE:INDIAGLYCO
Watchlist
Price: 1 284.2 INR 1.15% Market Closed
Market Cap: 39.8B INR
Have any thoughts about
India Glycols Ltd?
Write Note

India Glycols Ltd
Income from Continuing Operations

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

India Glycols Ltd
Income from Continuing Operations Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Income from Continuing Operations CAGR 3Y CAGR 5Y CAGR 10Y
I
India Glycols Ltd
NSE:INDIAGLYCO
Income from Continuing Operations
â‚ą1.6B
CAGR 3-Years
-17%
CAGR 5-Years
5%
CAGR 10-Years
N/A
Supreme Industries Ltd
NSE:SUPREMEIND
Income from Continuing Operations
â‚ą10.9B
CAGR 3-Years
-2%
CAGR 5-Years
20%
CAGR 10-Years
15%
Tata Chemicals Ltd
NSE:TATACHEM
Income from Continuing Operations
-â‚ą1.8B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
11%
Deepak Nitrite Ltd
NSE:DEEPAKNTR
Income from Continuing Operations
â‚ą8.6B
CAGR 3-Years
-4%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Berger Paints India Ltd
NSE:BERGEPAINT
Income from Continuing Operations
â‚ą11.5B
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
16%
Solar Industries India Ltd
NSE:SOLARINDS
Income from Continuing Operations
â‚ą10.7B
CAGR 3-Years
45%
CAGR 5-Years
28%
CAGR 10-Years
21%
No Stocks Found

India Glycols Ltd
Glance View

Market Cap
39.8B INR
Industry
Chemicals

India Glycols Ltd. operates as a holding company, which engages in the manufacture of industrial chemicals such as green technology based bulk, specialty and performance chemicals and natural gums and industrial gases, ethyl alcohol (Potable) and nutraceuticals. The company is headquartered in Kolkata, West Bengal. The Company’s segments include Bio-based Glycols (MEG, DEG, TEG and Heavy Glycols), Glycol Ethers, Glycol Ether Acetates, Ethylene Oxide Derivatives (EODs), Power Alcohol (Bio Fuel), Industrial Gases, Natural Gum (Bio Polymers), Ethyl Alcohol (Potable Spirits) and Extra Neutral Alcohol (ENA)and Ennature Biopharma (Nutraceuticals). Its products are Glycols (Bio-Based Specialties and Performance Chemicals), Ethyl Alcohol (Potable Spirits), Plant-based APIs and Nutraceuticals, Natural Gums (Bio Polymers), and Derivatives and Industrial Gases.

INDIAGLYCO Intrinsic Value
1 688.01 INR
Undervaluation 24%
Intrinsic Value
Price
I

See Also

What is India Glycols Ltd's Income from Continuing Operations?
Income from Continuing Operations
1.6B INR

Based on the financial report for Jun 30, 2024, India Glycols Ltd's Income from Continuing Operations amounts to 1.6B INR.

What is India Glycols Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 5Y
5%

Over the last year, the Income from Continuing Operations growth was 0%. The average annual Income from Continuing Operations growth rates for India Glycols Ltd have been -17% over the past three years , 5% over the past five years .

Back to Top